Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts-Reference-Cited by-同舟云学术

Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts

Published:2022-01 Issue:1 Volume:86 Page:252-255
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Pahalyants Vartan,Murphy William S.,Klebanov Nikolai,Lu Chenyue,Theodosakis Nicholas,Klevens R. Monina,Estir Hossein,Lilly Evelyn,Asgari Maryam,Semenov Yevgeniy R.

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. A survey of psoriasis patients on biologics during COVID-19: a single centre experience;Burlando;J Dermatolog Treat,2020

2. Factors associated with adverse COVID-19 outcomes in patients with psoriasis–insights from a global registry-based study;Mahil;J Allergy Clin Immunol,2021

3. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry;Strangfeld;Ann Rheum Dis,2021

4. Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases;Gianfrancesco;Curr Opin Rheumatol,2020

5. Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population;Hooijberg;Lancet Rheumatol,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine;Frontiers in Immunology;2024-01-30

2. The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study;Dermatologic Therapy;2023-12-26

3. A critical review of COVID-19 course and vaccination in dermatology patients on immunomodulatory/biologic therapy: recommendations should not differ between non-pregnant and pregnant individuals;Frontiers in Medicine;2023-06-02

4. The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness;Current Dermatology Reports;2023-04-03

5. A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases;Virology Journal;2023-01-07